✦ LIBER ✦

Ribavirin in the treatment of chronic hepatitis C

✍ Scribed by Paul Martin; Donald M Jensen

Book ID: 108951833
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 356 KB
Volume: 23
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05398.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of interferon alfa 2b

Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C

✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th

Interferon alpha and ribavirin in the tr

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C

✍ Magdalena Figlerowicz; Wojciech Sluzewski; Arleta Kowala-Piaskowska; Iwona Mozer 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 162 KB

Pegylated interferons in combination wit

Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 313 KB

Pegylated interferon α-2b plus ribavirin

Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients

✍ Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenthe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Peginterferon α-2a (40 KD) plus ribaviri

Peginterferon α-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients

✍ Makoto Kuboki; Shiro Iino; Tadao Okuno; Masao Omata; Kendo Kiyosawa; Hiromitsu K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Interferon alfa-2b in combination with r

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics

✍ Regino P. González-Peralta; Deirdre A. Kelly; Barbara Haber; Jean Molleston; Kar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Chronic hepatitis C virus (HCV) infection is usually asymptomatic in children, but significant liver disease may occur. We evaluated the efficacy, safety, and pharmacokinetics of interferon alfa-2b and ribavirin in children with chronic HCV. We determined the optimal ribavirin dose in an initial coh